7 Hrs
Source:
اليوم السابع
New Injection Resetting Immune System for MS
Renewed hope surrounds the treatment of autoimmune diseases through a single injection of the innovative therapy JY231. This approach relies on reprogramming the body's immune cells using an in vivo CAR-T treatment, aiming to target B cells that attack the body's tissues in conditions such as multiple sclerosis and myasthenia gravis. A clinical trial involving 16 patients demonstrated that the therapy led to the production of CAR-T cells and symptom improvement, along with a temporary decrease in B cells and a reset of the immune system. However, the application is still in its early stages and requires further, larger studies to confirm its long-term safety and effectiveness.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)